Increased myeloperoxidase and lipid peroxide-modified protein in gynecological malignancies

Antioxidants and Redox Signaling

Volumn 3, Issue 6, 2001, Pages 1139-1146

  Song, Mingqing ^a   Santanam, Nalini ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LIPID PEROXIDE; LIPID PEROXIDE MODIFIED PROTEIN; MYELOPEROXIDASE; OXIDIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL GROWTH; CELL TYPE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR PROMOTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; OXIDATIVE STRESS; PEROXIDASE; PROTEIN BIOSYNTHESIS; PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 0035666316     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601317203648     Document Type: Article

References (20)

1. Oxidative stress and tumour cell proliferation
2. Neutrophil-mediated tumor cell cytotoxicity: Role of the peroxidase system
3. Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention?
4. Oxidative stress, human genetic variation, and disease
5. Evidence for a concerted reaction between lipid hydroperoxides and polypeptides
6. Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies
7. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
8. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers
9. Generation of a polyclonal antibody against lipid peroxide-modified proteins
10. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody
11. Estrogen binding by leukocytes during phagocytosis
12. Mechanisms of carcinogenesis: Focus on oxidative stress and electron transfer
13. Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina
14. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
15. Estradiol as an antioxidant: Incompatible with its physiological concentrations and function
16. Vitamin E supplementation decreases autoantibodies to oxidized-lipid protein complexes
17. Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants
18. Cell cycle control, checkpoint mechanisms, and genotoxic stress
19. Autoantibodies to markers of oxidative stress are elevated in women with endometriosis
20. Antioxidants differentially regulate activation of NF-κB, AP-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: Evidence that JNK and NF-κB activation are not linked to apoptosis